Cargando…
The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial
BACKGROUND: Diabetes is a major cause of worldwide morbidity and mortality. Diet and medication non-adherence are common among individuals with diabetes, making glycemic control difficult to attain. This study aimed to evaluate an intervention designed based on Health Action Process Approach (HAPA)...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725444/ https://www.ncbi.nlm.nih.gov/pubmed/34983628 http://dx.doi.org/10.1186/s13098-021-00773-x |
_version_ | 1784626118493470720 |
---|---|
author | Ranjbaran, Soheila Shojaeizadeh, Davoud Dehdari, Tahereh Yaseri, Mehdi Shakibazadeh, Elham |
author_facet | Ranjbaran, Soheila Shojaeizadeh, Davoud Dehdari, Tahereh Yaseri, Mehdi Shakibazadeh, Elham |
author_sort | Ranjbaran, Soheila |
collection | PubMed |
description | BACKGROUND: Diabetes is a major cause of worldwide morbidity and mortality. Diet and medication non-adherence are common among individuals with diabetes, making glycemic control difficult to attain. This study aimed to evaluate an intervention designed based on Health Action Process Approach (HAPA) to improve adherence to diet and medication among patients with type 2 diabetes in Tehran, Iran. METHODS: The study was a randomized controlled trial. A total of 248 patients with type 2 diabetes who had low diet and medication adherence were randomly allocated into two intervention (n = 124) and control (n = 124) groups. Intervention group received educational intervention during three months. HAPA constructs, diet and medication adherence, and Hemoglobin A1c (HbA1c) levels were assessed at baseline, one month and six months after the intervention. Mixed Model Analysis was used to compare between and within group changes in the outcomes. RESULTS: There was a statistically significant improvement in HbA1c levels after six months (7.77 ± 1.36% vs. 8.07 ± 1.52%, 95% CI, p < 0.001). Diet and medication adherence, intention, task self-efficacy, coping self-efficacy, recovery self-efficacy, action and coping planning, barriers, benefits and perceived social support were significantly improved one month and six months after the intervention (p < 0.001). CONCLUSION: Our intervention designed based on health action process approach led to improvements in diet and medication adherence, and HbA1c among the patients within one and six months. Trial registration: IRCT, IRCT20151208025431N4. Registered 10 March 2018, https://fa.irct.ir |
format | Online Article Text |
id | pubmed-8725444 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87254442022-01-06 The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial Ranjbaran, Soheila Shojaeizadeh, Davoud Dehdari, Tahereh Yaseri, Mehdi Shakibazadeh, Elham Diabetol Metab Syndr Research BACKGROUND: Diabetes is a major cause of worldwide morbidity and mortality. Diet and medication non-adherence are common among individuals with diabetes, making glycemic control difficult to attain. This study aimed to evaluate an intervention designed based on Health Action Process Approach (HAPA) to improve adherence to diet and medication among patients with type 2 diabetes in Tehran, Iran. METHODS: The study was a randomized controlled trial. A total of 248 patients with type 2 diabetes who had low diet and medication adherence were randomly allocated into two intervention (n = 124) and control (n = 124) groups. Intervention group received educational intervention during three months. HAPA constructs, diet and medication adherence, and Hemoglobin A1c (HbA1c) levels were assessed at baseline, one month and six months after the intervention. Mixed Model Analysis was used to compare between and within group changes in the outcomes. RESULTS: There was a statistically significant improvement in HbA1c levels after six months (7.77 ± 1.36% vs. 8.07 ± 1.52%, 95% CI, p < 0.001). Diet and medication adherence, intention, task self-efficacy, coping self-efficacy, recovery self-efficacy, action and coping planning, barriers, benefits and perceived social support were significantly improved one month and six months after the intervention (p < 0.001). CONCLUSION: Our intervention designed based on health action process approach led to improvements in diet and medication adherence, and HbA1c among the patients within one and six months. Trial registration: IRCT, IRCT20151208025431N4. Registered 10 March 2018, https://fa.irct.ir BioMed Central 2022-01-04 /pmc/articles/PMC8725444/ /pubmed/34983628 http://dx.doi.org/10.1186/s13098-021-00773-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ranjbaran, Soheila Shojaeizadeh, Davoud Dehdari, Tahereh Yaseri, Mehdi Shakibazadeh, Elham The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial |
title | The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial |
title_full | The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial |
title_fullStr | The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial |
title_full_unstemmed | The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial |
title_short | The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial |
title_sort | effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725444/ https://www.ncbi.nlm.nih.gov/pubmed/34983628 http://dx.doi.org/10.1186/s13098-021-00773-x |
work_keys_str_mv | AT ranjbaransoheila theeffectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial AT shojaeizadehdavoud theeffectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial AT dehdaritahereh theeffectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial AT yaserimehdi theeffectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial AT shakibazadehelham theeffectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial AT ranjbaransoheila effectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial AT shojaeizadehdavoud effectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial AT dehdaritahereh effectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial AT yaserimehdi effectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial AT shakibazadehelham effectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial |